Skip to main content

Disordered sleep and painful diabetic neuropathy

Pain symptoms from PDN can disrupt sleep, and disordered sleep can exacerbate pain. Learn about promising treatments for disordered sleep in people with PDN and the efficacy of treatments in improving pain and/or sleep quality.

Read more

Editor's Choice

YKL-40 linked to GI cancer risk in type 2 diabetes

Raised YKL-40 levels are associated with an increased risk for obesity-related and gastrointestinal cancers, particularly liver cancer, in people with type 2 diabetes.

Skin infection or lymphoma in a woman with type 2 diabetes?

Cutaneous lymphoma should be considered in patients with long-standing, poorly controlled type 2 diabetes and chronic non-healing skin lesions. In this case, primary cutaneous B-cell lymphoma was misdiagnosed as a skin infection.

The threat of childhood obesity

Childhood obesity is a growing global health concern, but how should obesity be defined and measured in children, and how does it impact health in the short and long term?

Clinical use of polygenic scores in type 2 diabetes

Explore the clinical potential of type 2 diabetes-related PGSs for risk prediction and screening of type 2 diabetes and its comorbidities and risk stratification, with attention to their global applicability.

Our tailored content service will keep you up to date…

Receive newsletters curated for the busy specialist by our expert editorial team

Keynote series | Spotlight on managing health in obesity

Obesity is a major contributor to cardiorenal metabolic disease, but its impact extends throughout the body. Understand how obesity can affect other organ systems and impact treatment, and whether weight-loss measures improve outcomes.

Prof. Eva L. Feldman
Prof. Jonette Keri
Developed by: Springer Medicine
Watch now
Video

Using CGM to optimize type 2 diabetes management with non-intensive insulin treatment in primary care

With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report. 

Supported by:
  • Abbott Diabetes Care
Prof. Samuel Seidu
Developed by: Adis
Listen now
Podcast

Case Studies

Skin infection or lymphoma in a woman with type 2 diabetes?

Cutaneous lymphoma should be considered in patients with long-standing, poorly controlled type 2 diabetes and chronic non-healing skin lesions. In this case, primary cutaneous B-cell lymphoma was misdiagnosed as a skin infection.

Delayed diagnosis of monogenic diabetes

Complete heterozygous deletion of HNF1B was incidentally discovered in a woman who was enrolled in a clinical trial for type 1 diabetes and received immunosuppressive treatment for 4 years when she was a child.

Treatment of MODY with an SGLT2 inhibitor

Adding empagliflozin to sulfonylurea improved glycemic control in a woman with maturity-onset diabetes of the young. No adverse effects were noted, including no increase in ketonemia or ketonuria.

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more

Current Reviews

Dose-dependent effects of omega-3 polyunsaturated fatty acids on C-reactive protein concentrations in cardiometabolic disorders: a dose–response meta-analysis of randomized clinical trials

C-reactive protein (CRP) has been shown to be one of the top biomarkers for predicting future primary and secondary cardiovascular events and is one of the most studied biomarkers (Arroyo-Espliguero et al. 2021 ; van Holten et al. 2013 ). The …

Advancing toward a curative frontier: an updated narrative review on stem-cell therapy in pediatric type 1 diabetes

Type 1 diabetes (T1D) remains one of the most prevalent chronic illnesses diagnosed in childhood, and is an immune-mediated disease directed against pancreatic β-cells, resulting in severe endogenous insulin deficiency and subsequent hyperglycemia …

The role of fecal microbiota transplantation in diabetes

Fecal microbiota transplantation (FMT) has emerged as a potential therapeutic strategy for modulating gut dysbiosis in diabetes mellitus. This review critically evaluates preclinical and clinical evidence on FMT in type 1 (T1D) and type 2 diabetes …

Diabetes Mellitus and Associated Vascular Disease: Pathogenesis, Complications, and Evolving Treatments

Diabetes mellitus is a metabolic disorder, characterized by elevated blood sugar levels (hyperglycemia) and insulin dysregulation. This disease is associated with morbidity and mortality, including significant potential vascular complications.

Episode 10: Disease-modifying therapy for type 1 diabetes

Reducing the burden of type 1 diabetes

Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.

Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.

Prof. Chantal Mathieu
Listen now
Podcast

CME & eLearning

Videos | Case Scenarios | Infographics (Link opens in a new window)

1.0 AMA PRA Category 1 Credit(s)

Refine the application of CGM technology in primary care to enhance the management of type 2 diabetes. Benefit from key updates and experiential learning using CGM devices, and practice your clinical decision-making skills.

Supported by:
  • Abbott
Developed by: Springer Healthcare IME

Vodcasts | Case Scenarios (Link opens in a new window)

Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.

This program is not available to users in the UK and US.

Supported by:
  • Novo Nordisk A/S
Developed by: Springer Healthcare IME

News | Expert Reviews | Cases (Link opens in a new window)

Treating children with hormone disorders is complex and requires tailored management. To help you provide the most effective care, we deliver resources covering adrenal, thyroid, pituitary, growth, and puberty disorders, obesity, and diabetes.

Supported by:
  • Merck Healthcare KGaA, Darmstadt, Germany
Developed by: Springer Healthcare IME

Further Reading

Clustering of childhood acute leukemia in Finland: a nationwide register-based study

Acute leukemia is the most common malignancy in children, yet its etiology remains largely unknown. Several somatic changes are required for the development of leukemia, and according to a prevailing hypothesis, the first often occurs during fetal …

Severe hypoglycaemia is associated with increased risk of adverse cardiovascular complications in adults with type 1 diabetes: risk mitigation using intermittently scanned continuous glucose monitoring

Despite advances in glycaemic management, people with type 1 diabetes remain at higher risk of CVD and CVD-related mortality than people without diabetes [ 1 ]. Data from the Swedish National Diabetes Register (NDR) reveal that people with type 1 …

Predictors of small-for-gestational-age infants in gestational diabetes mellitus: the impact of metformin use

Gestational diabetes mellitus (GDM) represents a significant health challenge, with prevalence rates ranging from 3 to 25%, depending on ethnic composition, diagnostic criteria employed, and underlying population characteristics [ 1 , 2 ]. This …

The relationship between shrunken pore syndrome and all-cause mortality in people with type 2 diabetes and normal renal function: the Fremantle Diabetes Study Phase II

Estimates of the GFR (eGFR) are similar regardless of whether they are generated from creatinine-based (eGFR creat ) or cystatin C-based (eGFR cyst ) equations in most individuals. However, substantially discordant eGFR creat and eGFR cyst results …

Related topics

Focus on insulin icodec

A thorough overview of the safety and efficacy of once-weekly basal insulin icodec in type 1 and 2 diabetes, covering pharmacology, pharmacokinetics, adverse effects, drug interactions, and dose recommendations.

Read more

Disordered sleep and painful diabetic neuropathy

Pain symptoms from PDN can disrupt sleep, and disordered sleep can exacerbate pain. Learn about promising treatments for disordered sleep in people with PDN and the efficacy of treatments in improving pain and/or sleep quality.

Read more